Last updated: February 19, 2026
Alavert is an over-the-counter antihistamine primarily used to treat allergy symptoms. Its active ingredient is loratadine, a non-sedating antihistamine. The drug is available in various formulations, including tablets and liquid gels, and is marketed under multiple brand names, with Alavert being a common OTC branded version.
Key Suppliers and Manufacturing Sources
1. Johnson & Johnson Consumer Inc.
- Role: Primary manufacturer of Alavert in the United States.
- Facilities: Production mainly occurs at J&J’s manufacturing plants in the U.S., including facilities in Pennsylvania and New Jersey.
- Market Share: Dominates the OTC loratadine segment in North America.
- Product Portfolio: Produces Alavert in 10 mg tablets and liquids; also markets other antihistamines.
2. Makers of Generic Loratadine
- Several pharma companies produce loratadine as generics, which are sold under various brand names and store brands. Key manufacturers include:
- Sandoz (Novartis)
- Teva Pharmaceuticals
- Mylan (now part of Viatris)
- Sun Pharmaceutical Industries
- Dr. Reddy’s Laboratories
- Many of these firms supply loratadine to store brand label owners and generic drug distributors.
3. Contract Manufacturing Organizations (CMOs)
- Some manufacturers produce loratadine for different brands under contract, including:
- Catalent
- Recipharm
- Hikma Pharmaceuticals
4. Supply Chain Considerations
- The active pharmaceutical ingredient (API) for loratadine is sourced from multiple suppliers globally, including suppliers in China and India.
- API manufacturing is centralized in companies like Corroborated suppliers in India and China, which supply to branded and generic drug makers.
5. Distribution Channels
- Major pharmaceutical wholesalers and distributors such as McKesson, Cardinal Health, and Cencora distribute Alavert and generic loratadine products nationwide in the U.S.
Regulatory and Supply Chain Impact
- FDA approvals: Alavert and its generics are registered and regulated by the U.S. Food and Drug Administration (FDA).
- Supply disruptions: Dependence on APIs from China and India has caused occasional shortages and supply chain disruptions, especially during global events impacting manufacturing logistics.
Summary Comparison: Branded vs. Generic Suppliers
| Parameter |
Alavert (Brand) |
Generic Loratadine Suppliers |
| Primary Manufacturer |
Johnson & Johnson |
Multiple (Sandoz, Teva, Mylan, Sun Pharma, Dr. Reddy's) |
| API Source |
In-house and contracted suppliers |
Imported primarily from India and China |
| Distribution |
Johnson & Johnson distribution network |
Distributors like McKesson and Cardinal Health |
| Market Share (US) |
Majority of OTC loratadine sales |
Significant share, especially store brands |
Key Takeaways
- Johnson & Johnson is the main producer of Alavert.
- Multiple generic manufacturers produce loratadine, serving as primary suppliers for store brands and generics.
- API manufacturing in Asia influences global supply stability.
- Distribution depends heavily on large pharmaceutical wholesalers.
- Supply chain vulnerabilities relate to international API sourcing and regulatory factors.
FAQs
1. Who supplies the active ingredient (loratadine) for Alavert?
Loratadine is produced by several API manufacturers in India and China, supplying both branded and generic drug companies globally.
2. Can generic loratadine products be considered interchangeable with Alavert?
Yes. FDA-approved generic loratadine has the same active ingredient and efficacy as Alavert and can be substituted directly.
3. Are there manufacturing plants outside of the U.S. producing Alavert?
Alavert is primarily produced by Johnson & Johnson in North America. Generic loratadine is manufactured worldwide, but Alavert-specific facilities are largely U.S.-based.
4. How have supply disruptions affected availability?
Supply disruptions in API production or logistics from Asian suppliers have occasionally caused shortages of loratadine products, including Alavert.
5. What companies hold licensing or distribution rights for Alavert?
Johnson & Johnson holds rights for Alavert in the U.S. and distributes through its established OTC marketing channels.
References
- U.S. Food and Drug Administration. (2022). Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations. https://www.accessdata.fda.gov/scripts/cder/ob/index.cfm
- IQVIA. (2022). OTC market insights and market share reports.
- Johnson & Johnson. (2022). Annual Report 2022.
- Indian Pharmacopeia Commission. (2021). API manufacturing overview.
- European Medicines Agency. (2022). Generic loratadine approval records.
